Cargando…
Health technology assessment: oncology drugs with orphan designation as an example
Autor principal: | |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2958374/ http://dx.doi.org/10.1186/1750-1172-5-S1-O17 |
_version_ | 1782188329313239040 |
---|---|
author | Wild, Claudia |
author_facet | Wild, Claudia |
author_sort | Wild, Claudia |
collection | PubMed |
description | |
format | Text |
id | pubmed-2958374 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-29583742010-10-22 Health technology assessment: oncology drugs with orphan designation as an example Wild, Claudia Orphanet J Rare Dis Oral Presentation BioMed Central 2010-10-19 /pmc/articles/PMC2958374/ http://dx.doi.org/10.1186/1750-1172-5-S1-O17 Text en Copyright ©2010 Wild; licensee BioMed Central Ltd. |
spellingShingle | Oral Presentation Wild, Claudia Health technology assessment: oncology drugs with orphan designation as an example |
title | Health technology assessment: oncology drugs with orphan designation as an example |
title_full | Health technology assessment: oncology drugs with orphan designation as an example |
title_fullStr | Health technology assessment: oncology drugs with orphan designation as an example |
title_full_unstemmed | Health technology assessment: oncology drugs with orphan designation as an example |
title_short | Health technology assessment: oncology drugs with orphan designation as an example |
title_sort | health technology assessment: oncology drugs with orphan designation as an example |
topic | Oral Presentation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2958374/ http://dx.doi.org/10.1186/1750-1172-5-S1-O17 |
work_keys_str_mv | AT wildclaudia healthtechnologyassessmentoncologydrugswithorphandesignationasanexample |